Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Bayer Launches l'strogel without NHI Price Listing
August 20, 2007
- Number of Essential GCP Documents to Be Halved
August 20, 2007
- Takeda to License CCR5 Antagonists to Tobira Therapeutics
August 20, 2007
- Korosho Wants to See 1/4-1/3 of World's New Drugs Developed in Japan: New Industry Vision
August 6, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 6, 2007
- BUSINESS NEWS IN BRIEF
August 6, 2007
- New Nycomed to Go Global through Partnering
August 6, 2007
- Makers' Accountability Essential to Implement JPMA's Proposal: FPMAJ President
August 6, 2007
- Exelon Skin Patch Recommended for European Approval: Novartis
August 6, 2007
- Metronidazole-Based 3-Drug Combination to Be Approved for Hp Eradication
August 6, 2007
- 10 New Drugs (6 APIs) Recommended for Approval
August 6, 2007
- REGULATORY NEWS IN BRIEF
August 6, 2007
- TOPICS／Asahi Kasei Publishes FY2007 IP Report
August 6, 2007
- SURVEY／Majority of Users Do not Obtain Viagra from Hospitals
August 6, 2007
- Kyowa Hakko Licenses New Antibody Engineering Technology to BioWa
August 6, 2007
- Merck to Acquire NovaCardia
August 6, 2007
- R&D NEWS IN BRIEF
August 6, 2007
- Eisai Licenses Eszopiclone from Sepracor
August 6, 2007
- Elmed Eisai Conducts PMS on 2 of Its Generic Products
August 6, 2007
- Kissei Enters into Agreement with Nuon Therapeutics on Rizaben
August 6, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…